These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20016523)

  • 1. Comparison of the efficacy of candesartan and losartan: a meta-analysis of trials in the treatment of hypertension.
    Meredith PA; Murray LS; McInnes GT
    J Hum Hypertens; 2010 Aug; 24(8):525-31. PubMed ID: 20016523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Angiotensin-II receptor inhibitors in hemodialysed uremia patients with arterial hypertension: candesartan cilexitil versus losartan].
    Cice G; Ferrara L; Tagliamonte E; Russo PE; Di Benedetto A; Iacono A
    Cardiologia; 1999 Dec; 44(12):1071-6. PubMed ID: 10687258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of candesartan cilexetil and losartan in patients with systemic hypertension. Candesartan Versus Losartan Efficacy Comparison (CANDLE) Study Group.
    Gradman AH; Lewin A; Bowling BT; Tonkon M; Deedwania PC; Kezer AE; Hardison JD; Cushing DJ; Michelson EL
    Heart Dis; 1999; 1(2):52-7. PubMed ID: 11720604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A placebo-controlled comparison of the efficacy and tolerability of candesartan cilexetil, 8 mg, and losartan, 50 mg, as monotherapy in patients with essential hypertension, using 36-h ambulatory blood pressure monitoring.
    Baguet JP; Nisse-Durgeat S; Mouret S; Asmar R; Mallion JM
    Int J Clin Pract; 2006 Apr; 60(4):391-8. PubMed ID: 16620350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH).
    Palma Gámiz JL; Pêgo M; Contreras EM; Anglada MP; Martínez JO; Esquerra EA; Sagastagoitia Gorostiza JD;
    Clin Ther; 2006 Dec; 28(12):2040-51. PubMed ID: 17296460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review and meta-analysis of candesartan and losartan in the management of essential hypertension.
    Zhenfeng Zheng ; Huilan Shi ; Junya Jia ; Dong Li ; Shan Lin
    J Renin Angiotensin Aldosterone Syst; 2011 Sep; 12(3):365-74. PubMed ID: 21421652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of losartan versus candesartan on uric acid, renal function, and fibrinogen in patients with hypertension and hyperuricemia associated with diuretics.
    Rayner BL; Trinder YA; Baines D; Isaacs S; Opie LH
    Am J Hypertens; 2006 Feb; 19(2):208-13. PubMed ID: 16448895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of randomized controlled trials comparing telmisartan with losartan in the treatment of patients with hypertension.
    Xi GL; Cheng JW; Lu GC
    Am J Hypertens; 2008 May; 21(5):546-52. PubMed ID: 18437146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative clinical- and cost-effectiveness of candesartan and losartan in the management of hypertension and heart failure: a systematic review, meta- and cost-utility analysis.
    Grosso AM; Bodalia PN; Macallister RJ; Hingorani AD; Moon JC; Scott MA
    Int J Clin Pract; 2011 Mar; 65(3):253-63. PubMed ID: 21284790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial comparing the velocities of the antihypertensive effects on home blood pressure of candesartan and candesartan with hydrochlorothiazide.
    Hosaka M; Metoki H; Satoh M; Ohkubo T; Asayama K; Kikuya M; Inoue R; Obara T; Hirose T; Imai Y;
    Hypertens Res; 2015 Oct; 38(10):701-7. PubMed ID: 26041602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
    Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Rakugi H; Ogihara T; Miyata Y; Sasai K; Totsuka N
    Clin Ther; 2012 Apr; 34(4):838-48. PubMed ID: 22440192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigations of the antihypertensive long-term action of candesartan cilexetil in different dosages under the influence of therapy-free intervals].
    Weisser B; Gerwe M; Braun M; Funken C
    Arzneimittelforschung; 2005; 55(9):505-13. PubMed ID: 16229114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A forced titration study of antihypertensive efficacy of candesartan cilexetil in comparison to losartan: CLAIM Study II.
    Vidt DG; White WB; Ridley E; Rahman M; Harris S; Vendetti J; Michelson EL; Wang R;
    J Hum Hypertens; 2001 Jul; 15(7):475-80. PubMed ID: 11464257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of randomized trials of telmisartan versus losartan for reduction of ambulatory blood pressure.
    Takagi H; Niwa M; Mizuno Y; Goto SN; Umemoto T;
    Hypertens Res; 2013 Nov; 36(11):959-66. PubMed ID: 23945962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Meta-analysis of antihypertensive effect of telmisartan versus candesartan in patients with essential hypertension.
    Zhao D; Liu H; Dong P
    Clin Exp Hypertens; 2019; 41(1):75-79. PubMed ID: 29589977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Losartan/hydrochlorothiazide combination vs. high-dose losartan in patients with morning hypertension--a prospective, randomized, open-labeled, parallel-group, multicenter trial.
    Ueda T; Kai H; Imaizumi T;
    Hypertens Res; 2012 Jul; 35(7):708-14. PubMed ID: 22399096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulse pressure lowering effect of dual blockade with candesartan and lisinopril vs. high-dose ACE inhibition in hypertensive type 2 diabetic subjects: a CALM II study post-hoc analysis.
    Knudsen ST; Andersen NH; Poulsen SH; Eiskjaer H; Hansen KW; Helleberg K; Poulsen PL; Mogensen CE
    Am J Hypertens; 2008 Feb; 21(2):172-6. PubMed ID: 18188164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.